{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:54:30Z","timestamp":1791849270384,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.disamonth.2023.101582","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:43:37Z","timestamp":1683531817000},"page":"101582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Diabetic neuropathy: Pathogenesis and evolving principles of management"],"prefix":"10.1016","volume":"69","author":[{"given":"Basem","family":"Zaino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashika","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Devaragudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeshkumar","family":"Vaghamashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashendra","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirja","family":"Kaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2023.101582_bib0001","unstructured":"IDF Diabetes Atlas 2021 IDF diabetes atlas. Accessed February 3, 2023. https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.4498","article-title":"Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016","volume":"174","author":"Andes","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015599","article-title":"The Hoorn Diabetes Care System (DCS) cohort. A prospective cohort of persons with type 2 diabetes treated in primary care in the Netherlands","volume":"7","author":"Van Der Heijden","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01200-7","article-title":"Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications","volume":"20","author":"Sun","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.disamonth.2023.101582_bib0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/qjmed\/91.11.733","article-title":"Diabetic peripheral neuropathy and quality of life","volume":"91","author":"Benbow","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.disamonth.2023.101582_bib0006","author":"Anandhanarayanan","year":"2023","journal-title":"Diabetic Neuropathies"},{"key":"10.1016\/j.disamonth.2023.101582_bib0007","doi-asserted-by":"crossref","unstructured":"Eva L Feldman. Management of diabetic neuropathy. UpToDate. Accessed March 31, 2023. http:\/\/www.uptodate.com","DOI":"10.1097\/01.ASM.0000938852.60627.fa"},{"key":"10.1016\/j.disamonth.2023.101582_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802973-2.00015-X","article-title":"Peripheral neuropathies","volume":"138","author":"Hanewinckel","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.disamonth.2023.101582_bib0009","first-page":"12","article-title":"Advances in screening, early diagnosis and accurate staging of diabetic neuropathy","author":"Carmichael","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp.2005.075119","article-title":"Additional causes for distal sensory polyneuropathy in diabetic patients","volume":"77","author":"Gorson","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.disamonth.2023.101582_bib0011","first-page":"1655","article-title":"Diabetic foot ulcers: pathogenesis and management","volume":"66","author":"Frykberg","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.disamonth.2023.101582_bib0012","unstructured":"Mayo Clinic Staff. Diabetic neuropathy types: symptoms tell the story - Mayo Clinic. Published 2022. Accessed March 19, 2023. https:\/\/www.mayoclinic.org\/diseases-conditions\/diabetic-neuropathy\/in-depth\/diabetic-neuropathy-types\/art-20094456"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0013","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ncl.2020.03.010","article-title":"Diabetic lumbosacral radiculoplexus neuropathy (Diabetic Amyotrophy)","volume":"38","author":"Glenn","year":"2020","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0014","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1210\/er.2018-00161","article-title":"Diabetic gastroparesis","volume":"40","author":"Bharucha","year":"2019","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0015","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic autonomic neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101582_bib0016","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00041327-199512000-00004","article-title":"Simultaneous, multiple cranial neuropathies in diabetes mellitus","volume":"15","author":"Eshbaugh","year":"1995","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101582_bib0017","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: a meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.disamonth.2023.101582_bib0019","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.me.26.020175.002513","article-title":"Hyperglycemia, polyol metabolism, and complications of diabetes mellitus","volume":"26","author":"Gabbay","year":"1975","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(94)90088-4","article-title":"Effect of \u03b1-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve","volume":"126","author":"Nickander","year":"1994","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101582_bib0021","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.disamonth.2023.101582_bib0022","unstructured":"Ryle Catherine. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus - Ryle - 1997 - Muscle & Nerve - Wiley Online Library. Published 1998. Accessed March 30, 2023. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/28SICI\/291097-4598\/28199705\/2920\/3A5\/3C577\/3A\/3AAID-MUS6\/3E3.0.CO\/3B2-6"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2004.05.159","article-title":"Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells","volume":"320","author":"Sekido","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.disamonth.2023.101582_bib0024","first-page":"1","article-title":"Chapter 1 - classification, risk factors, and clinical presentation diabetic neuropathy","author":"Yavuz","year":"2023","journal-title":"Diabetic Neuropathy"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.disamonth.2023.101582_bib0026","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","article-title":"Glucose control and diabetic neuropathy: lessons from recent large clinical trials","volume":"14","author":"Ang","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"7","key":"10.1016\/j.disamonth.2023.101582_bib0027","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2337\/diacare.20.7.1162","article-title":"Risk factors for diabetic peripheral sensory neuropathy: results of the seattle prospective diabetic foot study","volume":"20","author":"Adler","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.disamonth.2023.101582_bib0028","article-title":"Painful diabetic neuropathy: the need for new approaches","author":"Yeung","year":"2023","journal-title":"J Diabetes Sci Technol Published Online First"},{"key":"10.1016\/j.disamonth.2023.101582_bib0029","article-title":"Understanding diabetic neuropathy: focus on oxidative stress","author":"Pang","year":"2023","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.disamonth.2023.101582_bib0030","doi-asserted-by":"crossref","unstructured":"Raghav A, Singh M, Jeong GB, Giri R, Agarwal S, Kala S. New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: a translational prospective review. Front Endocrinol (Lausanne). 13. doi:10.3389\/FENDO.2022.1036220","DOI":"10.3389\/fendo.2022.1036220"},{"key":"10.1016\/j.disamonth.2023.101582_bib0031","first-page":"156","article-title":"Drug repurposing - a search for novel therapy for the treatment of diabetic neuropathy","author":"Paul","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.disamonth.2023.101582_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114059","article-title":"Inhibiting apoptosis of Schwann cell under the high-glucose condition: a promising approach to treat diabetic peripheral neuropathy using Chinese herbal medicine","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"589","key":"10.1016\/j.disamonth.2023.101582_bib0033","article-title":"Challenges of neuropathic pain: focus on diabetic neuropathy","volume":"127","author":"Rosenberger","year":"2023","journal-title":"J Neural Transm"},{"key":"10.1016\/j.disamonth.2023.101582_bib0034","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1248\/yakushi.22-00121","article-title":"Elucidation and application of novel action of therapeutic agents for diabetic neuropathy","volume":"142","author":"Sato","year":"2023","journal-title":"Yakugaku Zasshi"},{"issue":"1-2","key":"10.1016\/j.disamonth.2023.101582_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2011.01.005","article-title":"Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells","volume":"234","author":"Leger","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.disamonth.2023.101582_bib0036","first-page":"1639","article-title":"FDA approved drugs repurposing of toll-like receptor4 (TLR4) candidate for neuropathy, Iran","volume":"18","author":"Zali","year":"2023","journal-title":"J Pharm Res IJPR"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0037","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000003077","article-title":"Oral dimethyl fumarate reduces peripheral neuropathic pain in rodents via NFE2L2 antioxidant signaling","volume":"132","author":"Li","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.disamonth.2023.101582_bib0038","first-page":"163","article-title":"Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy","author":"Ma","year":"2022","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0039","doi-asserted-by":"crossref","first-page":"e32653","DOI":"10.1097\/MD.0000000000032653","article-title":"Mechanism of Schwann cells in diabetic peripheral neuropathy: a review","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.disamonth.2023.101582_bib0040","article-title":"Hypertension the \u201cMissed modifiable risk factor\u201d for diabetic neuropathy: a systematic review","volume":"27","author":"Sethi","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.disamonth.2023.101582_bib0041","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.disamonth.2023.101582_bib0042","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0009-8981(87)90251-8","article-title":"Measurement by bioluminescence technique of erythrocyte membrane Na+,K+-ATPase activity in hypertensive patients","volume":"163","author":"Lechi","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.disamonth.2023.101582_bib0043","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nbd.2013.07.019","article-title":"The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes","volume":"62","author":"Visser","year":"2023","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.disamonth.2023.101582_bib0044","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-012-1012-6","article-title":"Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats","volume":"124","author":"Gregory","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.disamonth.2023.101582_bib0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ajh\/hpz058","article-title":"Hypertension contributes to neuropathy in patients with type 1 diabetes","volume":"32","author":"Ponirakis","year":"2023","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.disamonth.2023.101582_bib0046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-015-0005-8","article-title":"Association of chronic diabetes and hypertension in sural nerve morphometry: an experimental study","volume":"7","author":"Sanada","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0047","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/dc20-1842","article-title":"Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD trial","volume":"44","author":"Tang","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.disamonth.2023.101582_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.534372","article-title":"Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: estimates of the INTERPRET-DD Study","volume":"8","author":"Lu","year":"2020","journal-title":"Front Public Health"},{"issue":"Supplement_1","key":"10.1016\/j.disamonth.2023.101582_bib0049","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.2337\/dc23-S012","article-title":"12. retinopathy, neuropathy, and foot care: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101582_bib0050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","article-title":"Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options","volume":"9","author":"Veves","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.disamonth.2023.101582_bib0051","unstructured":"ModFXMedia J. The 5 stages of peripheral neuropathy. Accessed March 29, 2023. https:\/\/www.selecthealthtc.com\/five-stages-of-neuropathy\/"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0052","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e328014979e","article-title":"Diabetic neuropathy: classification, measurement and treatment","volume":"14","author":"Boulton","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0053","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.clinthera.2022.03.012","article-title":"Vitamin D in the prevention and treatment of diabetic neuropathy","volume":"44","author":"Putz","year":"2022","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0054","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101582_bib0055","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1017\/S0317167100040701","article-title":"End-stage complications of diabetic neuropathy: foot ulceration","volume":"21","author":"Boulton","year":"1994","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.disamonth.2023.101582_bib0056","unstructured":"Anandhanarayanan A, Teh K, Goonoo M, Tesfaye S, Selvarajah D. Diabetic neuropathies. Endotext. Published online March 15, 2022. Accessed February 3, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279175\/"},{"issue":"7","key":"10.1016\/j.disamonth.2023.101582_bib0057","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4239\/wjd.v7.i7.153","article-title":"Diabetic foot disease: From the evaluation of the \u201cfoot at risk\u201d to the novel diabetic ulcer treatment modalities","volume":"7","author":"Amin","year":"2016","journal-title":"World J Diabetes"},{"issue":"964","key":"10.1016\/j.disamonth.2023.101582_bib0058","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.2005.036137","article-title":"Diabetic neuropathy","volume":"82","author":"Bansal","year":"2006","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101582_bib0059","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4093\/dmj.2018.0056","article-title":"Diagnosing diabetic neuropathy: something old, something new","volume":"42","author":"Petropoulos","year":"2018","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.disamonth.2023.101582_bib0060","article-title":"Scoring systems to screen for diabetic peripheral neuropathy","author":"Yang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.disamonth.2023.101582_bib0061","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1001\/jama.2015.13611","article-title":"Distal symmetric polyneuropathy: a review","volume":"314","author":"Callaghan","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.disamonth.2023.101582_bib0062","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.disamonth.2023.101582_bib0063","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0064","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","article-title":"The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy","volume":"13","author":"Singleton","year":"2008","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0066","first-page":"240","article-title":"Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the united kingdom screening test scoring system, bio-thesiometry and aesthesiometry","volume":"13","author":"Oguejiofor","year":"2010","journal-title":"Nigerian J Clin Practice Sept"},{"key":"10.1016\/j.disamonth.2023.101582_bib0067","first-page":"12","article-title":"Gold standard for diagnosis of DPN","author":"Yu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0068","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","article-title":"Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee","volume":"98","author":"Price","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2023.101582_bib0069","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2091960","article-title":"Quality of life in painful peripheral neuropathies: a systematic review","volume":"2019","author":"Girach","year":"2019","journal-title":"Pain Res Manag"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101582_bib0071","first-page":"372","article-title":"Pharmacological treatment of diabetic peripheral neuropathy","volume":"40","author":"Cohen","year":"2015","journal-title":"Pharm Therapeutics"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0072","first-page":"166","article-title":"Pain associated with diabetic peripheral neuropathy: a review of available treatments","volume":"33","author":"St Onge","year":"2008","journal-title":"P T"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101582_bib0073","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/ds18-0036","article-title":"Update on the management of diabetic neuropathy","volume":"31","author":"Ang","year":"2018","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.disamonth.2023.101582_bib0074","unstructured":"Shindel AW, Lue TF. Sexual dysfunction in diabetes.; 2000."},{"key":"10.1016\/j.disamonth.2023.101582_bib0075","author":"Song","year":"2022","journal-title":"Diabetic Foot Care"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0076","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.apmr.2015.12.026","article-title":"Effects of a novel therapeutic intervention in patients with diabetic peripheral neuropathy","volume":"97","author":"Alshahrani","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.disamonth.2023.101582_bib0077","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221109390","article-title":"Treating peripheral neuropathy in individuals with type 2 diabetes mellitus with intraneural facilitation: a single blind randomized control trial","volume":"50","author":"Sahba","year":"2022","journal-title":"J Int Med Res"},{"key":"10.1016\/j.disamonth.2023.101582_bib0078","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.disamonth.2023.101582_bib0079","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101582_bib0080","first-page":"165","volume":"30","author":"Ghavami","year":"2018","journal-title":"Agri"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0081","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1464-5491.2011.03510.x","article-title":"Does vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?","volume":"29","author":"Shehab","year":"2012","journal-title":"Diabetic Medicine"},{"issue":"9","key":"10.1016\/j.disamonth.2023.101582_bib0082","doi-asserted-by":"crossref","DOI":"10.2174\/1573399817666210118145550","article-title":"The role of alpha-lipoic acid supplementation in the prevention of diabetes complications: a comprehensive review of clinical trials","volume":"17","author":"Jeffrey","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101582_bib0083","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1177\/0300060518756540","article-title":"Effect of \u03b1-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy","volume":"46","author":"Agathos","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1016\/j.disamonth.2023.101582_bib0084","doi-asserted-by":"crossref","unstructured":"Fan Q, Gordon Smith A. Recent updates in the treatment of diabetic polyneuropathy. 2022;11. doi:10.12703\/R\/11-30","DOI":"10.12703\/r\/11-30"},{"issue":"24","key":"10.1016\/j.disamonth.2023.101582_bib0085","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1212\/WNL.0000000000004033","article-title":"Effect of omega-3 supplementation on neuropathy in type 1 diabetes","volume":"88","author":"Lewis","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101582_bib0086","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.2040-1124.2010.00083.x","article-title":"Recent advances in the management of diabetic distal symmetrical polyneuropathy","volume":"2","author":"Tesfaye","year":"2011","journal-title":"J Diabetes Investig"},{"issue":"10","key":"10.1016\/j.disamonth.2023.101582_bib0087","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.disamonth.2023.101582_bib0088","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101582_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102738","article-title":"The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts\u2019 Consensus","volume":"20","author":"Giacomelli","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.disamonth.2023.101582_bib0090","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/ijms22126532","article-title":"Ovarian cancer immunotherapy and personalized medicine","volume":"22","author":"Morand","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502923000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502923000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:04:31Z","timestamp":1757898271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502923000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0011502923000627"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2023.101582","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic neuropathy: Pathogenesis and evolving principles of management","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2023.101582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101582"}}